Abnormal Centrosome Amplification in the Absence of p53

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Science

• Publication date

  1996-03-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/science.271.5256.1744PMID 8596939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

  1996cited by this paper
• Overexpression of mos oncogene product in Swiss 3T3 cells induces apoptosis preferentially during S-phase.

  1995cited by this paper
• p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

  1995cited by this paper
• Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.

  1995cited by this paper
• p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis.

  1995cited by this paper
• Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice.

  1995cited by this paper
• A UV-responsive G2 checkpoint in rodent cells

  1995cited by this paper
• Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells

  1995cited by this paper
• A p53-dependent mouse spindle checkpoint

  1995cited by this paper
• Microtubule organizing centers and gamma-tubulin.

  1994cited by this paper
• Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes

  1994cited by this paper
• Cell cycle control and cancer.

  1994cited by this paper
• Mediation of c-Myc-induced apoptosis by p53.

  1994cited by this paper
• Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice.

  1994cited by this paper
• Microtubule organizing centers and γ-tubulin

  1994cited by this paper
• Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.

  1994cited by this paper
• Pericentrin, a highly conserved centrosome protein involved in microtubule organization.

  1994cited by this paper
• Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.

  1993cited by this paper
• Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.

  1993cited by this paper
• Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts.

  1993cited by this paper
• In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.

  1993cited by this paper
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

  1993cited by this paper
• p53 mutations increase resistance to ionizing radiation.

  1993cited by this paper
• Oncogenic forms of p53 inhibit p53-regulated gene expression

  1992cited by this paper
• Wild-type p53 activates transcription in vitro

  1992cited by this paper
• Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

  1992cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

  1992cited by this paper
• The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

  1992cited by this paper
• Wild-type p53 binds to the TATA-binding protein and represses transcription.

  1992cited by this paper
• Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

  1992cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper
• Oncogenic forms of p53 inhibit p53-regulated gene expression.

  1992cited by this paper
• Inhibition of viral and cellular promoters by human wild-type p53

  1992cited by this paper
• A transcriptionally active DNA-binding site for human p53 protein complexes

  1992cited by this paper
• Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.

  1992cited by this paper
• Negative regulation of Rb expression by the p53 gene product.

  1992cited by this paper
• Gamma-tubulin: the microtubule organizer?

  1992cited by this paper
• Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

  1992cited by this paper
• γ-Tubulin: the microtubule organizer?

  1992cited by this paper
• Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer.

  1991cited by this paper
• Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.

  1991cited by this paper
• Wild-type p53 can down-modulate the activity of various promoters.

  1991cited by this paper
• Microsurgical removal of centrosomes blocks cell reproduction and centriole generation in BSC-1 cells.

  1991cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• Friend virus-induced erythroleukemia and the multistage nature of cancer.

  1991cited by this paper
• Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• The intracellular distribution of the transformation-associated protein p53 in adenovirus-transformed rodent cells.

  1988cited by this paper
• Independence of centriole formation and initiation of DNA synthesis in Chinese hamster ovary cells.

  1986cited by this paper
• Microtubule organizing centers.

  1985cited by this paper
• Microtubule nucleating sites in higher plant cells identified by an auto-antibody against pericentriolar material

  1985cited by this paper
• Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus

  1985cited by this paper
• Centrosome development in early mouse embryos as defined by an autoantibody against pericentriolar material.

  1983cited by this paper
• Anticentromere and anticentriole antibodies in the scleroderma spectrum.

  1983cited by this paper
• Centriole cycle in Chinese hamster ovary cells as determined by whole- mount electron microscopy

  1981cited by this paper
• THE CENTRIOLE CYCLE IN SYNCHRONIZED HELA CELLS

  1968cited by this paper

• Radiation-induced Centrosome Amplification and Genome Instability

  2026cites this paper
• Cholangiocytes' Primary Cilia Regulate DNA Damage Response and Repair.

  2025cites this paper
• Deficiency in POLE exonuclease causes synthetic lethality in highly aneuploid cancer cells

  2025cites this paper
• M-phase-specific generation of supernumerary centrioles in cancer cells.

  2025cites this paper
• Potential involvement of KANK1 haploinsufficiency in centrosome aberrations.

  2024cites this paper
• Development of a centrosome amplification-associated signature in kidney renal clear cell carcinoma based on multiple machine learning models

  2024cites this paper
• The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregation

  2023cites this paper
• Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer

  2023cites this paper
• The fate of extra centrosomes in newly formed tetraploid cells: should I stay, or should I go?

  2023cites this paper
• Mathematical modeling the order of driver gene mutations in colorectal cancer

  2023cites this paper
• TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness

  2023cites this paper
• High prevalence and dependence of centrosome clustering in mesenchymal tumors and leukemia

  2023cites this paper
• Permission to pass: on the role of p53 as a gatekeeper for aneuploidy

  2023cites this paper
• Centrosome Dysfunctions in Cancer.

  2022cites this paper
• Estrogens—Origin of Centrosome Defects in Human Cancer?

  2022cites this paper
• Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification

  2022cites this paper
• Development of Advanced Imaging and Molecular Imaging for Barrett’s Neoplasia

  2022cites this paper
• Keep Calm and Carry on with Extra Centrosomes

  2022cites this paper
• Computational benchmarking of putative KIFC1 inhibitors

  2022cites this paper
• Polo-like kinase 4 (Plk4) potentiates anoikis-resistance of p53KO mammary epithelial cells by inducing a hybrid EMT phenotype

  2022cites this paper
• The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells

  2021cites this paper
• On the role of p53 in the cellular response to aneuploidy

  2021cites this paper
• Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors

  2021cites this paper
• Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions

  2021cites this paper
• Generation and Fates of Supernumerary Centrioles in Dividing Cells

  2021cites this paper
• Spontaneous and inherited TP53 genetic alterations

  2021cites this paper
• Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy

  2021cites this paper
• Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma

  2020cites this paper
• Centrosome dysfunction: a link between senescence and tumor immunity

  2020cites this paper
• Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma

  2020cites this paper
• IQGAP1 control of centrosome function defines distinct variants of triple negative breast cancer

  2020cites this paper
• Cell Cycle, DNA Replication, Centrosomes, Centrioles and Cell Division

  2020cites this paper
• The primary cilium: its role as a tumor suppressor organelle.

  2020cites this paper
• Moonlighting in Mitosis: Analysis of the Mitotic Functions of Transcription and Splicing Factors

  2020cites this paper
• Overcome cancer drug resistance by targeting epigenetic modifications of centrosome

  2019cites this paper
• The toxic effect of cytostatics on primary cilia frequency and multiciliation

  2019cites this paper
• Sirenomelia and maternal chlamydia trachomatis infection: a case report and review

  2019cites this paper
• Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53

  2019cites this paper
• Genetic variation and radiation quality impact cancer promoting cellular phenotypes in response to HZE exposure.

  2019influential citation
• Targeting centrosome amplification, an Achilles' heel of cancer

  2019cites this paper
• Anti‐centrosome antibodies: Prevalence and disease association in Chinese population

  2019cites this paper
• Lawrence Berkeley National Laboratory Recent Work Title Genetic variation and radiation quality impact cancer promoting cellular phenotypes in response to HZE exposure Permalink

  2019cites this paper
• Nutrition and Cancer

  2019cites this paper
• A brief review on chemical agents involved in chromosomal aberrations in military wars

  2019cites this paper
• The Cell Cycle, Cytoskeleton and Cancer

  2019cites this paper
• Toxoplasma gondii-induced host cellular cell cycle dysregulation is linked to chromosome missegregation and cytokinesis failure in primary endothelial host cells

  2019cites this paper
• Control of metabolism by p53 – Cancer and beyond

  2018cites this paper
• 53BP1: A guardian for centrosomal integrity.

  2018cites this paper
• The Impact of Centrosome Pathologies on Prostate Cancer Development and Progression.

  2018cites this paper
• Computational design of small interfering RNAs and small hairpin RNAs to silence mutated P53 gene expressions

  2018cites this paper
• The contribution of discoidin domain receptor 1 to the pathogenesis of diffuse large B cell lymphoma

  2018cites this paper
• Molecular mechanisms of salamander limb regeneration

  2018cites this paper
• The effect of the Progesterone-Induced Blocking Factor (PIBF) on E-cadherin expression, cell motility and invasion of primary tumour cell lines.

  2018cites this paper
• CLINICAL AND TRANSLATIONAL IMPLICATIONS OF CENTROSOME AMPLIFICATION AND CLUSTERING IN MULTIPLE MALIGNANCIES

  2018cites this paper
• Functions and dysfunctions of the mammalian centrosome in health, disorders, disease, and aging

  2018cites this paper
• Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity

  2018cites this paper
• A look into centrosome abnormalities in colon cancer cells, how they arise and how they might be targeted therapeutically

  2018cites this paper
• Over-elongation of centrioles in cancer promotes centriole amplification and chromosome missegregation

  2018cites this paper
• Effect of Benzo[a]Pyrene on Spindle Misorientation and Fidelity of Chromosome Segregation in Lung Epithelial BEAS-2B Cells

  2018cites this paper
• Once and only once: mechanisms of centriole duplication and their deregulation in disease

  2018cites this paper
• Hypoxia Induced Centrosome Amplification Underlies Aggressive Disease Course in HPV-Negative Oropharyngeal Squamous Cell Carcinoma

  2018cites this paper
• Chromosomes and Chromosomal Instability in Human Cancer

  2017cites this paper
• The tobacco carcinogen NNK disturbs mitotic chromosome alignment by interrupting p53 targeting to the centrosome.

  2017cites this paper
• Updates from the TP53 universe

  2017cites this paper
• Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM

  2017cites this paper
• Centrosome amplification: a suspect in breast cancer and racial disparities.

  2017cites this paper
• Depletion of tumor suppressor Kank1 induces centrosomal amplification via hyperactivation of RhoA

  2017cites this paper
• Plk1-mediated stabilization of 53BP1 through USP7 regulates centrosome positioning to maintain bipolarity

  2017cites this paper
• Mycobacteria exploit nitric oxide‐induced transformation of macrophages into permissive giant cells

  2017cites this paper
• 7 Centrosome Abnormality and Human Lung Cancer

  2017cites this paper
• Centrosome Amplification Is Sufficient to Promote Spontaneous Tumorigenesis in Mammals.

  2017cites this paper
• Chromosomal Instability in Gastric Cancer Biology

  2017cites this paper
• Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers

  2017cites this paper
• DDX3 localizes to the centrosome and prevents multipolar mitosis by epigenetically and translationally modulating p53 expression

  2017cites this paper
• Cdk2 catalytic activity is essential for meiotic cell division in vivo.

  2016cites this paper
• Induction of giant cells by the synthetic food colorants viz. lemon yellow and orange red

  2016cites this paper
• Functional Significance of Aurora Kinases–p53 Protein Family Interactions in Cancer

  2016cites this paper
• Aneuploidy impairs protein folding and genome integrity in human cells

  2016cites this paper
• Tumor-Derived Factors and Reduced p53 Promote Endothelial Cell Centrosome Over-Duplication

  2016cites this paper
• A Review of Centriole Activity, and Wrongful Activity, during Cell Division

  2016cites this paper
• Chlamydia cell biology and pathogenesis

  2016cites this paper
• Genome Stability Requires p53.

  2016cites this paper
• Methods to Study Metastasis in Genetically Modified Mice.

  2016cites this paper
• Centrosome cohesion: functions of C-NAP1

  2016cites this paper
• Drugging the addict: non‐oncogene addiction as a target for cancer therapy

  2016cites this paper
• Cep70 overexpression stimulates pancreatic cancer by inducing centrosome abnormality and microtubule disorganization

  2016cites this paper
• Centrosomal nucleolin is required for microtubule network organization

  2015cites this paper
• NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability

  2015cites this paper
• Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer

  2015cites this paper
• Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy

  2015cites this paper
• Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.

  2015cites this paper
• p16 Gene Transfer Induces Centrosome Amplification and Abnormal Nucleation Associated with Survivin Downregulation in Glioma Cells

  2015cites this paper
• Preclinical Murine Models for Lung Cancer: Clinical Trial Applications

  2015cites this paper
• TRIM28 Is an E3 Ligase for ARF-Mediated NPM1/B23 SUMOylation That Represses Centrosome Amplification

  2015cites this paper
• p53 checkpoint ablation exacerbates the phenotype of Hinfp dependent histone H4 deficiency

  2015cites this paper
• Gallic acid induces mitotic catastrophe and inhibits centrosomal clustering in HeLa cells.

  2015cites this paper
• Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse

  2015cites this paper
• Impacts of DNA damage on the pericentriolar material and centriole duplication

  2015cites this paper
• Chronic centrosome amplification without tumorigenesis

  2015cites this paper
• The Characterization of the Novel Chloroquine Derivative VR23 for its Anticancer Properties

  2015cites this paper